Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Warner-Lambert updates U.S. status of Rezulin

Jan. 18, 1999

Novel antidiabetic agents in development at Novo Nordisk

Jan. 18, 1999

More PDE5 inhibitors in the Pfizer pipeline

Jan. 18, 1999

Combination of lovastatin and acipimox for type II diabetes and mixed dyslipidemia

Jan. 15, 1999

Amantadine reverses adverse effects of neuroleptic drugs on sexual function in males

Jan. 15, 1999

Amylin files IND for antidiabetes drug and reports on feasibility of alternative delivery routes

Jan. 15, 1999

Amylin gears up for regulatory filing of pramlintide and presents new clinical data

Jan. 15, 1999

Novel compounds developed at Roche for lipid disorders and fungal infections

Jan. 15, 1999

Traditional Chinese medicine shows potential as Rx for hypercholesterolemia

Jan. 14, 1999

TKT and Sumitomo collaborate to commercialize Fabry's disease treatment in Asia

Jan. 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...